play an essential role in the etiology of IGEs, and it has been reported that many IGE-related genes are responsible for encoding canal proteins 4 . Recent studies indicated that the molecular mechanisms underlying the IGEs are mutations in some critical ion and non-ion channel protein encoding genes. Mutations in ME2, LGI4, EFHC1, and EFHC2, which encode non-ion channel proteins and KCNJ10, KCNJ3, KCNQ2/KCNQ3, CLCN2, GABRG2, GABRA1, SC-N1B, and SCN1A, which encode ion channel proteins have been implicated in epilepsy
The EFHC2 gene is mapped to chromosome Xp11. 4 ; it contains 15 exons and encodes a 749-amino acid protein, and contains three DM10 domains and three calcium-binding EF-hand motives 5 . DM10-1 domain is located between amino acids 75-182 (108 amino acids), while the 143-amino acid containing DM10-2 and 108-amino acid containing DM10-3 domains are located between amino acids 226-368 and 431-538, respectively. The 36-amino acid containing EF-hand domain is located at a region within amino acids 558-593. Alter-native splicing produces two isoforms of the protein.
The second isoform is a 162-amino acid product without the amino acids 1-587 6 . Gu et al. reported a tentative relation between the S430Y polymorphism of EFHC2 gene in patients suffering from Juvenile Myoclonic Epilepsy (JME), an IGE sub syndrome, and epilepsy. They emphasized that independent replication studies are required to further analyse the relation between S430Y polymorphism and IGE 5 . In this study, we have examined whether there is relation between S430Y polymorphism of EFHC2 gene and IGE.
Materıal and methods

Patient and control groups
Patient group: 42 male and 54 female patients, mean aged 31.35, diagnosed clinically with IGE at the Department of Neurology of Faculty of Medicine, Celal Bayar University were included in the study. In terms of seizure type, patients with IGE (n = 96) were tonic-clonic (n = 77), absence (n = 8), tonic (n = 4), atonic (n = 3), myoclonic (n = 4). All patients gave fully informed consents to participate in the study, and 3 mL of a blood sample was taken from each of them.
Control group: 46 male and 50 female patients, mean aged 34.90, who presented to the Department of Neurology but did not have epilepsy or a condition which epilepsy-related genes are implicated comprised the control group. All control subjects gave fully informed consents to participate in the study, and 3 mL of blood samples were taken from them.
Genomic DNA isolation
Genomic DNA isolation was carried out in accordance with the manufacturer's protocol using 3 mL blood drawn from the subjects into collection tubes with EDTA (High Pure PCR Template Preparation Kit Ref# 11 796 828 001 Roche Diagnostics GmbH, Mannheim, Germany).
Analysis of S430Y polymorphism in EFHC2 Gene by real-time PCR
Using the extracted DNA, the design of the primers and probes used for the analysis of G/T base substitution causing amino acid exchange S430Y in EFHC2 was undertaken by a commercial company (TIB MOL-BIOL GmbH, Berlin, Germany) (Table1). LightCycler Faststart DNA Master Probe mix was obtained from a commercial company (Ref# 03 003 248 001 Roche Diagnostics GmbH, Mannheim, Germany). PCR mix was prepared for the PCR reaction. PCR mix with a final volume of 20 µl included 2µl forward primer (0.5µM at 1x concentration), 2µl reverse primer (0.5 µM at 1x concentration), 2µl fluorescent-labeled probe (0.2 µM at 1x concentration), 2µl LC Red 640 labeled probe (0.2 µM at 1x concentration), 2µl Taq DNA Polymerase(1x), 3.4 µl distilled water (H2O, PCR grade), 1.6 µl MgCl2 (3mM at 1x concentration) and 5µl genomic template DNA (5-25 ng/µl). PCR reaction conditions are presented in Table 2 . Melting curve analysis was gathered by LightCycler Software 3.05.
Statistical analysis
Student T test was used to compare the difference in mean ages between the patient and control groups. Chisquare test and Fisher's Exact Test were used for comparison of parameters related to G>T polymorphism that caused amino acid exchange S430Y, for sex distribution and for within-group comparison of the data obtained from the patient group. The level of significance was set at p<0.05 for both tests.
Results
Genotyping
Three different genotypes emerge when serine is substituted with tyrosine at position 430 (S430Y) as a result of G>T exchange at nucleotide 1289 of EFHC2 gene. Subjects with G/G genotype (wild type) were normal, those with G/T genotype were heterozygote, and those with T/T genotype were homozygote. EFHC2 is a gene found at X chromosome (Xp11.4). While genotyping, hemizygote males with G>T polymorphism were considered homozygote since males have a single X chromosome. According Figure 1 . Age, sex, type of IGE seizure, age at first seizure, family history of epilepsy and genotypes related to S430Y polymorphism in EFHC2 gene are presented in Table 4 . Subjects in the patient group were divided into 3 groups in terms of age, namely "39 and under" "between 40-59" and"60 and over". The relation between age group and type of seizure was assessed by Chi-square test and no significant relation was found (p>0.05) ( Table 5 ). Presence of a relation between the type of IGE seizure in the Patient Group and S430Y polymorphism genotype was tested by chi-square test, and we found that the difference was not statistically significant (p>0.05) (Table 6 ). 
Statistical analysis
Table 3 depicts the data pertaining to the 96 patients di agnosed with IGE and 96 subjects in the control group.
Discussion
The genes calcium-binding EF-hand motifs 1 (EFHC1) and 2 (EFHC2) are responsible for the encoding of non-ion channel proteins which have been suggested to interact with ion channels, and hence they are associated with the development of epilepsy. Especially the amino acid exchange S430Y in exon 9 of EFHC2 was investigated in JME patients 5 . When the data obtained from our study was compared statistically, the differences between patient and control groups were found not to be significant (p>0.05). However, due to the chromosomal location of the gene, male and female patients should be assessed separately in terms of S430Y polymorphism. Even though X chromosomal inheritance has not been identified among the complex genetic trait model of IGE syndromes, presence of a single X chromosome in males should be taken into consideration.
In German population, Gu and colleagues 5 determined the polymorphisms in EFHC2 gene and their localizations. Also, authors reported a weak relation between S430Y (rs2208592) missense mutation and the epilepsy in 81 patients diagnosed with classical JME (without absence seizure), and they argued that S430Y polymorphism affected seizure susceptibility in male patients with JME 5 . In our study, 12 subjects in the control group (4 males and 8 females) and 13 patients (5 males and 8 females) in the patient group had S430Y polymorphism. When the control and patient groups were compared in terms of sex and presence of S430Y polymorphism, the differences were not statistically significant (p>0.05).
Types of seizures observed in IGE are tonic-clonic, myoclonic, atonic, tonic and absence seizures. Similar to generalized epilepsy with febrile seizures plus (GEFS+), fever may also accompany seizures in some forms of IGE 7 . It has been argued that some genes involved in IGE had influence on the type of seizure as well. KCN1A 8 and KCNJ10 9 , two of the ion-channel genes, could be risk factors for seizure even though these genes did not have a major effect on the development of epilepsy.
In the present study, among the 96 IGE patients, 77 had tonic-clonic, 8 had absence, 4 had tonic, 3 had atonic and 4 had myoclonic seizure. There was no statistically significant relation between the type of seizure and carrier state for S430Y polymorphisms in EFHC2 in the patient group (p>0.05).
In a previous study 5 , absence of a significant relation between JME and S430Y G>T polymorphism can be attributed to the presence of only 4 cases with JME during patient recruitment phase. Investigating S430Y amino acid exchange only in the JME group could yield different findings.
EFHC2 is the EFHC1 gene paralog in human genome. EFHC1 and EFHC 2 genes are expressed in cerebral neurons 5 . In our previous study, we found no evidence that EFHC1 is a major genetic factor for the development of IGE in Turkish patients, and we indicated that 685T>C and 662G>A polymorphisms might not be associated with IGE 10 . Hence, we considered that examined polymorphisms (in genes EFHC1 and EFHC2) might not be a major genetic risk factor in terms of IGE.
Data pertaining to the SNP that causes S430Y exchange (rs2208592) can be found at the web pages of National Institute of Health Sciences
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. This page lists S430Y genotype data obtained from 1245 patients from Asia, Europe, Africa, and various populations, and it shows that 956 patients had G/G, 71 had G/T, and 30 had T/T genotype 11 . In our study, of the 96 patients, 83 had G/G, 7 had G/T and 6 had T/T genotype, while 84 of 96 subjects in the control group had G/G, 8 had G/T, and 4 had T/T genotype. Being the first published data on S430Y polymorphism in Turkish population, we believe that the results of the present study will contribute to the knowledge base.
Conclusion
Present study in which the relation between idiopathic generalized epilepsy and G>T polymorphism resulting in S430Y amino acid exchange in EFHC2 is examined, one of the non-ion channel genes failed to show a statistically significant difference between the patient and control groups. The data on S430Y polymorphism genotypes in IGE patients and control subjects in Turkish population determined by real time PCR is the first of its kind. Data obtained in this study has the potential to set the ground for future studies.
